propofol has been researched along with Cholangiocellular Carcinoma in 1 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, HC | 1 |
| Lee, MS | 1 |
| Lin, KT | 1 |
| Chan, SM | 1 |
| Chen, JY | 1 |
| Lin, YT | 1 |
| Wu, ZF | 1 |
1 other study available for propofol and Cholangiocellular Carcinoma
| Article | Year |
|---|---|
Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in intrahepatic cholangiocarcinoma surgery.
Topics: Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Bile Duct Neoplasms; Cholangiocarcinoma; De | 2019 |